Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.

Medicare may cover Ozempic if a person requires it as a diabetes medication. In 2024 , Medicare stopped excluding Wegovy from coverage to treat obesity, which occurs along with cardiovascular disease.

More medicines will be spared from Medicare price negotiations, a change that is projected to wipe out billions in savings ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...